Korea Health Industry Development Institute (KHIDI)

Funds Korea's health industry development through commercialization support, medical manufacturing initiatives, and healthcare entrepreneurship.

Korea Health Industry Development Institute (KHIDI) is South Korea's government-affiliated health-industry institute under the Ministry of Health and Welfare. It plans, evaluates, and manages domestic healthcare R&D, while also serving as a policy think tank for the health industry and a commercialization bridge for companies working in drugs, devices, regenerative medicine, digital health, and smart hospitals.

The institute's core activity is health R&D support, and the record points to work on innovative new drugs, medical devices, regenerative medicine, big data, AI-based medical technologies, and broader healthcare infrastructure. Its related programs include the health industry R&D umbrella, the Korea Drug Development Fund for new-drug work, medical device promotion, smart hospital development, and regenerative medicine. KHIDI also operates the Biohealth Innovation Start-up Center and has overseas offices in the United States, the UAE, China, and Kazakhstan.

KHIDI combines domestic project management with global market building. The Medical Korea conference launched in 2010, and the institute uses international cooperation, patient-facing programs, and overseas offices to support Korea's pharmaceutical and medical-device industries abroad. The published outcomes cited in the record include 30 new drugs, 213 medical devices, 79 international technology transfers, and 679 clinical trials, which makes KHIDI one of the more operationally active health-sector funders in the region.